Chemours (CC) Receivables (2014 - 2026)

Chemours has reported Receivables for 13 years, with the latest figure at $809.0 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 7.29% year-over-year to $809.0 million; the trailing twelve-month figure through Mar 2026 stood at $809.0 million (up 7.29% YoY), and the FY2025 full-year result was $612.0 million, down 6.71% from the prior year.
• Receivables for Q1 2026 stood at $809.0 million, up from $612.0 million in the prior quarter.
• The five-year high for Receivables was $1.1 billion in Q1 2022, with the low at $612.0 million in Q4 2025.
• Average Receivables over 5 years is $858.3 million, with a median of $863.0 million recorded in 2025.
• Year-over-year, Receivables jumped 52.19% in 2022 and dropped 26.07% in 2023.
• Tracing CC's Receivables over 5 years: stood at $726.0 million in 2022, then decreased by 11.57% to $642.0 million in 2023, then advanced by 2.18% to $656.0 million in 2024, then decreased by 6.71% to $612.0 million in 2025, then surged by 32.19% to $809.0 million in 2026.
• The last three Receivables figures came in at $809.0 million (Q1 2026), $612.0 million (Q4 2025), and $997.0 million (Q3 2025), per Business Quant data.

Peer Comparison